Page 1494 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 1494
Chapter 83 Virus-Associated Lymphoma 1329
Keegan TH, Glaser SL, Clarke CA, et al: Epstein-Barr virus as a marker of Rudek MA, Flexner C, Ambinder RF: Use of antineoplastic agents in patients
survival after Hodgkin’s lymphoma: a population-based study. J Clin with cancer who have HIV/AIDS. Lancet Oncol 12:905, 2011.
Oncol 23:7604, 2005. Savoldo B, Goss JA, Hammer MM, et al: Treatment of solid organ transplant
Kelly GL, Rickinson AB: Burkitt lymphoma: revisiting the pathogenesis of recipients with autologous Epstein Barr virus-specific cytotoxic T lympho-
a virus-associated malignancy. Hematology Am Soc Hematol Educ Program cytes (CTLs). Blood 108:2942, 2006.
2007:277, 2007. Sparano JA, Lee JY, Kaplan LD, et al: Rituximab plus concurrent infusional
Kitahata MM, Achenbach CJ, Saag MS: Age at cancer diagnosis among EPOCH chemotherapy is highly effective in HIV-associated B-cell non-
persons with AIDS. Ann Intern Med 154:642, 2011. Hodgkin lymphoma. Blood 115:3008, 2010.
Levine AM: HIV-associated lymphoma. Blood 115:2986, 2010. Uldrick TS, Polizzotto MN, Aleman K, et al: High-dose zidovudine plus
Libra M, Polesel J, Russo AE, et al: Extrahepatic disorders of HCV infection: valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric
a distinct entity of B-cell neoplasia? Int J Oncol 36:1331, 2010. Castleman disease: a pilot study of virus-activated cytotoxic therapy. Blood
Matsuoka M, Jeang KT: Human T-cell leukaemia virus type 1 (HTLV-1) 117:6977, 2011.
infectivity and cellular transformation. Nat Rev Cancer 7:270, 2007. Vereide DT, Sugden B: Lymphomas differ in their dependence on Epstein-
Matsuoka M, Jeang KT: Human T-cell leukemia virus type 1 (HTLV-1) Barr virus. Blood 117:1977, 2011.
and leukemic transformation: viral infectivity, Tax, HBZ and therapy.
Oncogene 30:1379, 2011.
Moore PS, Chang Y: KSHV: forgotten but not gone. Blood 117:6973, 2011.
Ratner L, Harrington W, Feng X, et al: Human T cell leukemia virus reactiva- REFERENCES
tion with progression of adult T-cell leukemia-lymphoma. PLoS ONE
4:e4420, 2009. For the complete list of references, log on to www.expertconsult.com.

